James Mandell, Director at bluebird bio, Inc. (BLUE), sold 8,000 shares at $75.04 ($600K) on 2017-01-31, disclosed to the SEC on 2017-02-02.
Open-market sale of $600k BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLUE | SELL | 2017-02-17 | $84K | — | Filing → |
| BLUE | SELL | 2017-02-16 | $952K | — | Filing → |
| BLUE | SELL | 2017-01-31 | $351K | — | Filing → |